Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 6;49(17):7904-16.
doi: 10.1021/ic100856n.

Synthesis of diamidopyrrolyl molybdenum complexes relevant to reduction of dinitrogen to ammonia

Affiliations

Synthesis of diamidopyrrolyl molybdenum complexes relevant to reduction of dinitrogen to ammonia

J M Chin et al. Inorg Chem. .

Abstract

A potentially useful trianionic ligand for the reduction of dinitrogen catalytically by molybdenum complexes is one in which one of the arms in a [(RNCH(2)CH(2))(3)N](3-) ligand is replaced by a 2-mesitylpyrrolyl-alpha-methyl arm, that is, [(RNCH(2)CH(2))(2)NCH(2)(2-MesitylPyrrolyl)](3-) (R = C(6)F(5), 3,5-Me(2)C(6)H(3), or 3,5-t-Bu(2)C(6)H(3)). Compounds have been prepared that contain the ligand in which R = C(6)F(5) ([C(6)F(5)N)(2)Pyr](3-)); they include [(C(6)F(5)N)(2)Pyr]Mo(NMe(2)), [(C(6)F(5)N)(2)Pyr]MoCl, [(C(6)F(5)N)(2)Pyr]MoOTf, and [(C(6)F(5)N)(2)Pyr]MoN. Compounds that contain the ligand in which R = 3,5-t-Bu(2)C(6)H(3) ([Ar(t-Bu)N)(2)Pyr](3-)) include {[(Ar(t-Bu)N)(2)Pyr]Mo(N(2))}Na(15-crown-5), {[(Ar(t-Bu)N)(2)Pyr]Mo(N(2))}[NBu(4)], [(Ar(t-Bu)N)(2)Pyr]Mo(N(2)) (nu(NN) = 2012 cm(-1) in C(6)D(6)), {[(Ar(t-Bu)N)(2)Pyr]Mo(NH(3))}BPh(4), and [(Ar(t-Bu)N)(2)Pyr]Mo(CO). X-ray studies are reported for [(C(6)F(5)N)(2)Pyr]Mo(NMe(2)), [(C(6)F(5)N)(2)Pyr]MoCl, and [(Ar(t-Bu)N)(2)Pyr]MoN. The [(Ar(t-Bu)N)(2)Pyr]Mo(N(2))(0/-) reversible couple is found at -1.96 V (in PhF versus Cp(2)Fe(+/0)), but the [(Ar(t-Bu)N)(2)Pyr]Mo(N(2))(+/0) couple is irreversible. Reduction of {[(Ar(t-Bu)N)(2)Pyr]Mo(NH(3))}BPh(4) under Ar at approximately -1.68 V at a scan rate of 900 mV/s is not reversible. Ammonia in [(Ar(t-Bu)N)(2)Pyr]Mo(NH(3)) can be substituted for dinitrogen in about 2 h if 10 equiv of BPh(3) are present to trap the ammonia that is released. [(Ar(t-Bu)N)(2)Pyr]Mo-N=NH is a key intermediate in the proposed catalytic reduction of dinitrogen that could not be prepared. Dinitrogen exchange studies in [(Ar(t-Bu)N)(2)Pyr]Mo(N(2)) suggest that steric hindrance by the ligand may be insufficient to protect decomposition of [(Ar(t-Bu)N)(2)Pyr]Mo-N=NH through a variety of pathways. Three attempts to reduce dinitrogen catalytically with [(Ar(t-Bu)N)(2)Pyr]Mo(N) as a "catalyst" yielded an average of 1.02 +/- 0.12 equiv of NH(3).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed intermediates in the reduction of dinitrogen at a [HIPTN3N]Mo (Mo) center (HIPT = hexaisopropylterphenyl) through stepwise addition of protons and electrons.
Figure 2
Figure 2
A “diamidopyrrolyl” complex.
Figure 3
Figure 3
Thermal ellipsoid drawing (50% probability) of the solid state structure of [(C6F5N)2Pyr]Mo(NMe2). H atoms are omitted for clarity. Selected bond distances (Å) and angles (°): N(5)-Mo(1) = 1.9383(12), Mo(1)-N(3) = 1.9738(12), Mo(1)-N(2) = 1.9885(12), Mo(1)-N(1) = 2.0807(12), Mo(1)-N(4) = 2.2630(12), C(21)-N(2)-Mo(1) = 129.36(10), C(31)-N(3)-Mo(1) = 128.3(3), N(1)-Mo(1)-N(4) = 77.26(5), N(2)-Mo(1)-N(4) = 78.61(5), N(3)-Mo(1)-N(4) = 77.51(5), N(5)-Mo(1)-N(4) = 176.92(5).
Figure 4
Figure 4
Thermal ellipsoid drawing (50% probability) of the solid state structure of [(C6F5N)2Pyr]MoCl. H atoms are omitted for clarity. Selected bond distances (Å) and angles (°): Cl(2)-Mo(1) = 2.3583(4), Mo(1)-N(3) = 1.9539(12), Mo(1)-N(2) = 1.9688(12), Mo(1)-N(1) = 2.0184(12), Mo(1)-N(4) = 2.1737(12), C(21)-N(2)-Mo(1) = 125.99(10), C(31)-N(3)-Mo(1) = 123.41(10), N(1)-Mo(1)-N(4) = 79.05(5), N(2)-Mo(1)-N(4) = 79.49(5), N(3)-Mo(1)-N(4) = 79.98(5), N(4)-Mo(1)-Cl(2) = 174.98(3).
Figure 5
Figure 5
Thermal ellipsoid drawing (50% probability) of the solid state structure of [(Art-BuN)2Pyr]Mo(NMe2). H atoms are omitted for clarity. Selected bond distances (Å) and angles (°): Mo(1)-N(5) = 1.6746(13), Mo(1)-N(4) = 2.4134(13), Mo(1)-N(1) = 2.0565(12), Mo(1)-N(2) = 1.9857(13), Mo(1)-N(3) = 1.9751(13), C(21)-N(2)-Mo(1) = 126.27(10), C(31)-N(3)-Mo(1) = 127.25(10), N(1)-Mo(1)-N(4) = 75.66(5), N(2)-Mo(1)-N(4) = 76.08(5), N(3)-Mo(1)-N(4) = 80.99(5), N(4)-Mo(1)-N(5) = 176.43(5).
Figure 6
Figure 6
Electrochemical behavior of {[(Art-BuN)2Pyr]Mo(N2)}(n-Bu)4N in 0.1M [NBu4]BAr′4 in PhF recorded at a glassy carbon electrode at 100mV/s to 900mV/s scan rates, referenced to Cp2Fe+/0.
Figure 7
Figure 7
IR spectrum of a C6D6 solution of [(Art-BuN)2Pyr]Mo(N2) and {[(Art-BuN)2Pyr]Mo(N2)}Na(THF)x after exposure to 15N2 for 2.5 h.
Figure 8
Figure 8
Electrochemical behavior of {[(Art-BuN)2Pyr]Mo(NH3)}BPh4 in 0.1M [NBu4]BAr′4 in PhF recorded at a glassy carbon electrode, referenced to Cp2Fe+/0.
Figure 9
Figure 9
Appearance of {[(Art-BuN)2Pyr]Mo(NH3)}BPh4 at scan rates of 10 and 50 mV/sec.

Similar articles

Cited by

References

    1. Burgess BK. Chem Rev. 1990;90:1377.
    2. Burgess BK, Lowe DJ. Chem Rev. 1996;96:2983. - PubMed
    3. Rees DC, Howard JB. Curr Opin Chem Biol. 2000;4:559. - PubMed
    4. Rees DC, Chan MK, Kim J. Adv Inorg Chem. 1996;40:89.
    5. Eady RR. Chem Rev. 1996;96:3013. - PubMed
    6. Howard JB, Rees DC. Chem Rev. 1996;96:2965. - PubMed
    7. Kim J, Woo D, Rees DC. Biochemistry. 1993;32:7104. - PubMed
    8. Kim J, Rees DC. Nature. 1992;360:553. - PubMed
    9. Bolin JT, Ronco AE, Morgan TV, Mortenson LE, Xuong LE. Proc Nat Acad Sci. 1993;90:1078. - PMC - PubMed
    10. Chen J, Christiansen J, Campobasso N, Bolin JT, Tittsworth RC, Hales BJ, Rehr JJ, Cramer SP. Angew Chem, Int Ed Engl. 1993;32:1592.
    11. Einsle O, Tezcan FA, Andrade SLA, Schmid B, Yoshida M, Howard JB, Rees DC. Science. 2002;297:1696. - PubMed
    12. Hardy RWF, Bottomley F, Burns RC. A Treatise on Dinitrogen Fixation. Wiley-Interscience; New York: 1979.
    13. Christiansen J, Dean DR, Seefeldt LC. Annu Rev Plant Physiol Plant Mol Biol. 2001;52:269. - PubMed
    14. Dos Santos PC, Igarashi RY, Lee H, Hoffman BM, Seefeldt LC, Dean DR. Acc Chem Res. 2005;38:208. - PubMed
    15. Dance I. Chem Asian J. 2007;2:936. - PubMed
    16. Kästner J, Blöchl PE. J Am Chem Soc. 2007;129:2998. - PubMed
    1. Allen AD, Senoff CV. J Chem Soc, Chem Commun. 1965:621.
    1. Fryzuk MD, Johnson SA. Coord Chem Rev. 2000;200–202:379.
    2. Hidai M, Mizobe Y. Chem Rev. 1995;95:1115.
    3. Hidai M. Coord Chem Rev. 1999;185–186:99.
    4. Chatt J, Dilworth JR, Richards RL. Chem Rev. 1978;78:589.
    5. Richards RL. Coord Chem Rev. 1996;154:83.
    6. Richards RL. Pure Appl Chem. 1996;68:1521.
    7. Bazhenova TA, Shilov AE. Coord Chem Rev. 1995;144:69.
    8. Shilov AE. Russ Chem Bull Int Ed. 2003;2:2555.
    9. MacKay BA, Fryzuk MD. Chem Rev. 2004;104:385. - PubMed
    10. Gambarotta S, Scott J. Angew Chem Int Ed. 2004;43:5298. - PubMed
    11. Hidai M, Mizobe Y. Can J Chem. 2005;83:358.
    1. Knobloch DJ, Lobkovsky E, Chirik PJ. Nat Chem. 2010;2:30. - PubMed
    2. Hanna TE, Lobkovsky E, Chirik PJ. Organometallics. 2009;28:4079.
    3. Munha RF, Veiros LF, Duarte MT, Fryzuk MD, Martins AM. Dalton Trans. 2009:7494. - PubMed
    4. Kozak CM, Mountford P. Angew Chem Int Ed. 2004;43:1186. - PubMed
    5. Fryzuk MD. Acc Chem Res. 2009;42:127. - PubMed
    6. Chirik PJ. Dalton Trans. 2007;16 - PubMed
    1. Smith JM, Lachicotte RJ, Holland PL. J Am Chem Soc. 2003;125:15752. - PubMed
    2. Eckert NA, Smith JM, Lachicotte RJ, Holland PL. Inorg Chem. 2004;43:3306. - PubMed
    3. Holland PL. Canad J Chem. 2005;83:296.
    4. Smith JM, Sadique AR, Cundari TR, Rodgers KR, Lukat-Rodgers G, Lachicotte RJ, Flaschenriem CJ, Vela J, Holland PL. J Am Chem Soc. 2006;128:756. - PubMed
    5. Field LD, Li HL, Magill AM. Inorg Chem. 2009;48:5. - PubMed
    6. Whited MT, Mankad NP, Lee Y, Oblad PF, Peters JC. Inorg Chem. 2009;48:2507. - PubMed
    7. Lee Y, Mankad NP, Peters JC. Nat Chem. 2010;2:558. - PMC - PubMed
    8. Crossland JL, Balesdent CG, Tyler DR. Dalton Trans. 2009:4420. - PubMed

Publication types